Duerr R.H., Taylor K.D., Brant S.R., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 5804 (2006) 1461-1463
Hampe J., Franke A., Rosenstiel P., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39 2 (2007) 207-211
Libioulle C., Louis E., Hansoul S., et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 3 4 (2007) 0538-0543
Parkes M., Barrett J.C., Prescott N.J., et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 39 7 (2007) 830-832
Rioux J.D., Xavier R.J., Taylor K.D., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39 5 (2007) 596-604
Barrett J.C., Hansoul S., Nicolae D.L., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40 8 (2008) 955-962
Fisher S.A., Tremelling M., Anderson C.A., et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 40 6 (2008) 710-712
Franke A., Balschun T., Karlsen T.H., et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 40 6 (2008) 713-715
Franke A., Balschun T., Karlsen T.H., et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 40 11 (2008) 1319-1323
Lakatos P.L. Recent trends in the epidemiology of inflammatory bowel diseases: up or down?. World J Gastroenterol 12 38 (2006) 6102-6108
Louis E., Collard A., Oger A.F., et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49 6 (2001) 777-782
Bunn S.K., Bisset W.M., Main M.J., et al. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 33 1 (2001) 14-22
Tibble J.A., Sigthorsson G., Foster R., et al. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 123 2 (2002) 450-460
Konikoff M.R., and Denson L.A. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 12 6 (2006) 524-534
Jones J., Loftus Jr. E.V., Panaccione R., et al. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol 6 11 (2008) 1218-1224
Ferrante M., Henckaerts L., Joossens M., et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 56 10 (2007) 1394-1403
Dubinsky M.C., Kugathasan S., Mei L., et al. Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Clin Gastroenterol Hepatol 6 10 (2008) 1105-1111
Triester S.L., Leighton J.A., Leontiadis G.I., et al. A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn's disease. Am J Gastroenterol 101 5 (2006) 954-964
Shamir R., and Eliakim R. Capsule endoscopy in pediatric patients. World J Gastroenterol 14 26 (2008) 4152-4155
Moy L., and Levine J. Wireless capsule endoscopy in the pediatric age group: experience and complications. J Pediatr Gastroenterol Nutr 44 4 (2007) 516-520
Liu Y.B., Liang C.H., Zhang Z.L., et al. Crohn disease of small bowel: multidetector row CT with CT enteroclysis, dynamic contrast enhancement, CT angiography, and 3D imaging. Abdom Imaging 31 6 (2006) 668-674
Ryan E.R., and Heaslip I.S. Magnetic resonance enteroclysis compared with conventional enteroclysis and computed tomography enteroclysis: a critically appraised topic. Abdom Imaging 33 1 (2008) 34-37
Desmond A.N., O'Regan K., Curran C., et al. Crohn's disease: factors associated with exposure to high levels of diagnostic radiation. Gut 57 11 (2008) 1524-1529
Masselli G., Casciani E., Polettini E., et al. Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn's disease. Eur Radiol 18 3 (2008) 438-447
Negaard A., Sandvik L., Berstad A.E., et al. MRI of the small bowel with oral contrast or nasojejunal intubation in Crohn's disease: randomized comparison of patient acceptance. Scand J Gastroenterol 43 1 (2008) 44-51
Kubota R., Yamada S., Kubota K., et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33 11 (1992) 1972-1980
Zhuang H., Yu J.Q., and Alavi A. Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol Clin North Am 43 1 (2005) 121-134
Bicik I., Bauerfeind P., Breitbach T., et al. Inflammatory bowel disease activity measured by positron-emission tomography. Lancet 350 9073 (1997) 262
Skehan S.J., Issenman R., Mernagh J., et al. 18F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease. Lancet 354 9181 (1999) 836-837
Lemberg D.A., Issenman R.M., Cawdron R., et al. Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis 11 8 (2005) 733-738
Neurath M.F., Vehling D., Schunk K., et al. Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol 97 8 (2002) 1978-1985
Loffler M., Weckesser M., Franzius C., et al. High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann N Y Acad Sci 1072 (2006) 379-385
Cook G.J., Maisey M.N., and Fogelman I. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med 26 10 (1999) 1363-1378
Kamel E.M., Thumshirn M., Truninger K., et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J Nucl Med 45 11 (2004) 1804-1810
Louis E., Ancion G., Colard A., et al. Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT. J Nucl Med 48 7 (2007) 1053-1059
Meisner R.S., Spier B.J., Einarsson S., et al. Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease. Inflamm Bowel Dis 13 8 (2007) 993-1000
Das C.J., Makharia G., Kumar R., et al. PET-CT enteroclysis: a new technique for evaluation of inflammatory diseases of the intestine. Eur J Nucl Med Mol Imaging 34 12 (2007) 2106-2114
Peloquin J.M., Pardi D.S., Sandborn W.J., et al. Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol 103 8 (2008) 2015-2022
Gelfand M.J., and Lemen L.C. PET/CT and SPECT/CT dosimetry in children: the challenge to the pediatric imager. Semin Nucl Med 37 5 (2007) 391-398
